Isoniazid-resistant disseminated mycobacterium tuberculosis in a Jamaican infant with HIV/AIDS

West Indian Medical Journal

Volumn 57, Issue 3, 2008, Pages 298-301

  Singh Minott, I ^a,b   Pierre, R B ^a,b   Olugbuyi, O ^a   Dunkley Thompson, J ^a   Haughton, D ^c   Christie, Celia D C ^a,b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

^c May Pen Hospital   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CIPROFLOXACIN; COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; NEVIRAPINE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BRONCHIOLITIS; BRONCHOPNEUMONIA; CASE REPORT; DEVELOPMENTAL DISORDER; DRUG WITHDRAWAL; FAILURE TO THRIVE; GASTROENTERITIS; HEPATOSPLENOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAMAICA; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MALE; MALNUTRITION; MILIARY TUBERCULOSIS; MIXED INFECTION; MUSCLE HYPERTONIA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERINATAL INFECTION; PNEUMOCYSTIS PNEUMONIA; PRESCHOOL CHILD; QUADRIPLEGIA; RECURRENT FEVER; RESPIRATORY DISTRESS; SINGLE DRUG DOSE; SUBCUTANEOUS NODULE; THRUSH; TUBERCULIN TEST; VIRUS LOAD; VOMITING;

ANTITUBERCULAR AGENTS; HIV INFECTIONS; HUMANS; INFANT; ISONIAZID; JAMAICA; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 55749100107     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. Geneva, World Health Organization (WHO/HTM/TB/2007.376). Accessed September 3, 2007 at http://www.who.int/tb/publications/ global_report/2007/pdf/full.pdf
2. Starke JR. Interferon-ã release assays for diagnosis of tuberculosis infection in children. Pediatr Infect Dis J. 2006; 25: 941-2.
3. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC et al. The growing burden of tuberculosis: global trends and interaction with HIV epidemic. Arch Intern Med 2003; 163: 1009-21.
4. Geoghagen M, Farr JA, Hambleton I, Pierre R, Christie CD. Tuberculosis and HIV co-infections in Jamaican children. West Indian Med J 2004; 53: 339-45.
5. Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis. 2002; 6: 1038-45.
6. de Charmace G, Delacourt C. Diagnostic techniques in paediatric tuberculosis. Paediatr Respir Rev 2001; 2: 120-6.
7. Khan EA, Starke JR. Diagnosis of tuberculosis in children: increased need for better methods. Emerg Infec Dis 1995: 1: 115-23.
8. World Health Organization. Anti-tuberculosis Drug Resistance Surveillance 1999-2002. Geneva, World Health Organization; 2004.
9. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. WHO report 2006. Geneva, World Health Organization (WHO/HTM/TB/2006.362).
10. Graham SM, Gie RP, Schaaf HS, Coulter JB, Espinal MA, Beyers N. Childhood tuberculosis: clinical research needs. Int J tuberc Lung Dis 2004; 8: 648-57.
11. Hesseling AC, Schaaf HS, Hanekom WA, Beyers N, Cotton MF, Gie RP et al. Danish bacille Calmette-Guerin vaccine-induced disease in human immunodeficiency virus-infected children. Clin Infect Dis 2003; 37: 1226-33.
12. Siberry GK, Tessema S. Immune reconstitution syndrome precipitated by bacille Calmette Guerin after initiation of antiretroviral therapy. Pediatr Infect Dis J 2006; 25: 648-9.
13. Puthanakit T, Oberdorfer P, Ukarapol N, Akarathum N, Punjaisee S, Sirisanthana T et al. Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection. Pediatr Infect Dis J 2006; 25: 645-8.
14. Bastian I, Colebunder SR. Treatment and prevention multidrug-resistant tuberculosis. Drugs 1999; 58: 633-61.
15. Schaad UB. Fluoroquinolone antibiotics in infants and children. Infect Dis Clin North Am 2005; 19: 617-28.
16. Burkhardt JE, Walterspiel JN, Schaad UB. Quinolone arthropathy in animal versus children. Clin Infect Dis 1997; 25: 1196-1204.
17. Graham SM, Gie RP, Schaaf HS, Coulter JB, Espinal MA, Beyers N. Childhood tuberculosis: clinical research needs. Int J Tuberc Lung Dis 2004; 8: 648-57.
18. Pavlopoulou ID, Theodoridou M, Daikos GL, Lazopoulou DK, Koudoumnakis E, Papadopoulos L et al. Drug-resistant tuberculous mastoiditis in 2 children. Scand J Infect Dis 2000; 32: 436-8.
19. Lindquist SW, Steinmetz BA, Starke JR. Multidrug-resistant tuberculosis of the first cervical vertebra in an immunocompetent adolescent. Pediatr Infect Dis J 1997; 16: 333-5.
20. Mehta JB, Mejia E, Gallemore GH, Ramsey GF. Drug-resistant tuberculosis of the brain in a two-year-old child. Tenn Med 1998; 91: 285-7.
21. Drobac PC, Mukherjee JS, Joseph JK, Mitnick C, Furin JJ, del Castillo H et al. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics 2006; 117: 2022-99.
22. Curtis AB, Ridzon R, Vogel R, McDonough S, Hargreaves J, Ferry J et al. Extensive transmission of mycobacterium tuberculosis from a child. N Engl J Med 1999; 341: 1491-5.
23. Stop TB Partnership and World Health Organization. Global Plan to Stop TB 2006-15. Geneva, World Health Organization, 2006. WHO/HTM/STB/2006.35.
24. World Health Organization. A research agenda for childhood tuberculosis. Geneva, World Health Organization, 2007. WHO/HTM/TB/2007.381. Accessed September 3, 2007 at http://www.who.int/tb/publications/2007/en/ index.html